Unlocking Tomorrow’s Cures - July 8, 2010
Unlocking tomorrow’s cures has been a primary goal for the Parkinson’s Action Network (PAN) since its inception. It is hugely important that we all work as hard as possible to push science forward. Only through that work will the treatments and cures of tomorrow become a reality for the millions of people who need them.
I recently spoke at an event with the Council for American Medical Innovation (CAMI). That event, much like PAN’s Emerging Therapies: From Microscope to Marketplace Interactive Webcast, addressed the hurdles we face in moving promising research through the drug development pipeline. Both of these discussions make it clear that there is so much more work to do.
The Emerging Therapies Webcast was a great success; over 600 people have participated via their own computers. Thanks again to our distinguished panel of experts and our generous supporters for making this event possible. Jackie Hunt Christensen, PAN’s Minnesota State Coordinator and a member of the Webcast panel, shares her thoughts on the event and what can be done in the future to highlight issues important to patients. PAN also continues work on two programs that will be key to unlocking tomorrow’s cures for Parkinson’s: the Cures Acceleration Network (CAN) and the Department of Defense Parkinson’s research program. This month, Joel Havemann gives much-deserved recognition to members of the Parkinson’s community who have lost a loved one and remain active in the advocacy community.
It is vital that we all take action on the issues affecting our community. Your voice is important, and your continued support allows us to serve as the unified voice of the Parkinson’s disease community.
Amy Comstock Rick
Chief Executive Officer
P.S.: I sincerely hope that you will join us on October 6, 2010 for PAN's 17th Annual Morris K. Udall Awards Dinner. 100% of the proceeds from this event support PAN's work. If you cannot attend, please consider making a donation or placing a message in our dinner program book.